The effects of anti-CD38 monoclonal antibody and anti-HI antibody on pretransfusion testing in a patient with multiple myeloma

doi:10.1007/s00277-023-05251-0

科研成果详情

题名	The effects of anti-CD38 monoclonal antibody and anti-HI antibody on pretransfusion testing in a patient with multiple myeloma
作者	Zhe Zhu 1; Kairui Hong2; Yefang Ke 3
发表日期	2023-05-05
发表期刊	Annals of hematology 影响因子和分区
语种	英语
原始文献类型	Letter
ISSN	0939-5555
EISSN	1432-0584
卷号	102 期号:7
DOI	10.1007/s00277-023-05251-0
收录类别	PUBMED
URL	查看原文
PubMed ID	37142876
引用统计
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/175236
专题	附属第一医院_输血科
作者单位	1.Department of Blood Transfusion, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.; 2.Department of Blood Transfusion, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; 3.Department of Clinical Laboratory, Ningbo Women & Children's Hospital, Liuting Street 339, Ningbo, Zhejiang, China. keyefang@foxmail.com.
推荐引用方式 GB/T 7714	Zhe Zhu,Kairui Hong,Yefang Ke. The effects of anti-CD38 monoclonal antibody and anti-HI antibody on pretransfusion testing in a patient with multiple myeloma[J]. Annals of hematology,2023,102(7).
APA	Zhe Zhu, Kairui Hong, & Yefang Ke. (2023). The effects of anti-CD38 monoclonal antibody and anti-HI antibody on pretransfusion testing in a patient with multiple myeloma. Annals of hematology, 102(7).
MLA	Zhe Zhu,et al."The effects of anti-CD38 monoclonal antibody and anti-HI antibody on pretransfusion testing in a patient with multiple myeloma".Annals of hematology 102.7(2023).